Connor, Clark & Lunn Investment Management (CC&L)
AXLA

Connor, Clark & Lunn Investment Management (CC&L)’s Axcella Health Inc. Common Stock AXLA Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio AXLA Stock Details AXLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-559
Closed -$4.58K – 1506
2022
Q4 		$4.58K Buy
+559
New +$14.5K ﹤0.01% 1176

Other funds holding AXLA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ZIM
Zacks Investment Management Chicago, Illinois $12.5B AUM 29.36% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s AXLA Position: Q1 2023 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Axcella Health Inc. Common Stock (AXLA) in Q1 2023, closing a stake of 559 shares — an estimated $4.58K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in AXLA in Q4 2022 and held it in 1 quarter. The position peaked at $4.58K in Q4 2022. 29 funds tracked by Wall St. Rank hold AXLA as of Q1 2023.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Axcella Health Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 559 Axcella Health Inc. Common Stock shares in Q1 2023, an estimated $4.58K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Axcella Health Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Axcella Health Inc. Common Stock position peaked at $4.58K in Q4 2022.
  • 29 funds tracked by Wall St. Rank held Axcella Health Inc. Common Stock as of Q1 2023.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2023, filed 10 May 2023.